Dr. John Allen is an Assistant Professor in the Department of Pharmacology and Toxicology at UTMB. Prior to coming to UTMB, he was the Principal Scientist and Laboratory Head at Pfizer Neuroscience where he participated in CNS drug discovery and development, pioneering research into signaling biased ligands for Dopamine D1 and D2 receptors in the treatment of Parkinson’s disease and schizophrenia. His lab at the UTMB Center for Addiction Research pursues receptor targeted strategies and drug discovery for the treatment of addiction and neuropsychiatric disorders. He is the recipient of several awards including a Research Starter Award from the PhRMA Foundation, Young Investigator Awards from NARSAD and the American College of Neuropsychopharmacology, and a Rising STAR Award from the University of Texas System.